BMRN
Biomarin Pharmaceutical IncCompany with tickers: BMRN
CIK
1048477
CUSIP
09061G101
Shares Outstanding
193,284,438
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $766,208,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | $194,999,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $178,796,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $129,640,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $105,527,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $0.55 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $0.54 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |